1 completed, 1 unknown. 2 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 1, Unknown 1 |
| Phase 1 | 1 | Unknown 1 |
Follow Blood And Marrow Transplantation: new trials by email Literature Review of Blood And Marrow Transplantation trials Research Report on Blood And Marrow Transplantation
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of ASC-101 in Patients With Hematologic Malignancies Who Receive Dual-cord Umbilical Cord Blood Transplantation Fludarabine, Clofarabine, Busulfan, ATG, TBI (Myeloablative), Fludarabine, Melphalan, ATG (Reduced Intensity) - Blood And Marrow Transplantation, Leukemia | Phase 1 / Phase 2 | Unknown | Targazyme, Inc. | 25 | 2013-11-01 | 2013-11-18 |
| Plerixafor for Stem Cell Mobilization in Normal Donors Filgrastim, Plerixafor, Apheresis Procedure - Blood And Marrow Transplantation | Phase 2 | Completed | M.D. Anderson Cancer Center | 22 | 2013-10-01 | 2019-04-23 |
Hodgkin Disease (1) · Leukemia (1) · Lymphoma (1) · Lymphoma, Non-Hodgkin (1) · Myelodysplastic Syndromes (1)
Bone Marrow Diseases (1) · Hematologic Diseases (1) · Hemic and Lymphatic Diseases (1) · Immune System Diseases (1) · Immunoproliferative Disorders (1) · Lymphatic Diseases (1) · Lymphoproliferative Disorders (1) · Neoplasms (1) · Neoplasms by Histologic Type (1)
Blood Component Removal (1) · Bone Marrow Purging (1) · Busulfan (1) · Clofarabine (1) · Filgrastim (1) · Granulocyte Colony-Stimulating Factor (1) · Melphalan (1) · Mycophenolic Acid (1) · Rituximab (1) · Tacrolimus (1) · Whole-Body Irradiation (1) · fludarabine (1) · plerixafor (1)
M.D. Anderson Cancer Center (1) · Targazyme, Inc. (1)
United States (2)
Chitra M. Hosing, MD (1) · Elizabeth Shpall, MD (1)